Topical formulations containing mTOR inhibitors
US11813250B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2022 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Sep 2, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A formulation for topical delivery of mTOR inhibitors with extended shelf-life. The formulation comprises an mTOR inhibitor, a solvent capable of dissolving and stabilizing the inhibitor. The use of the formulation for the treatment of skin lesions and other topical diseases is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.